Cumberland Pharmaceuticals Inc (CPIX) — Net Asset Quality Index
Cumberland Pharmaceuticals Inc (CPIX) has a Net Asset Quality Index of 27.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $62.88 Million minus total liabilities of $45.77 Million yields net assets of $17.11 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Cumberland Pharmaceuticals Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cumberland Pharmaceuticals Inc Net Asset Quality Index Over Time (2005–2025)
This chart shows how Cumberland Pharmaceuticals Inc's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of June 2026, the index stands at 27.2%, representing net assets of $17.11 Million against total assets of $62.88 Million USD. For live market cap and overall valuation, see market value of Cumberland Pharmaceuticals Inc.
Annual Net Asset Quality Index for Cumberland Pharmaceuticals Inc (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for Cumberland Pharmaceuticals Inc from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check CPIX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 31.9% | $24.54 Million | $76.82 Million | $52.28 Million | ▲ +2.1 pp |
| 2024 | 29.8% | $22.55 Million | $75.58 Million | $53.04 Million | ▼ -6.0 pp |
| 2023 | 35.8% | $29.26 Million | $81.78 Million | $52.52 Million | ▼ -2.9 pp |
| 2022 | 38.7% | $35.97 Million | $92.93 Million | $56.95 Million | ▼ -11.7 pp |
| 2021 | 50.4% | $42.60 Million | $84.46 Million | $41.86 Million | ▲ +1.8 pp |
| 2020 | 48.6% | $46.87 Million | $96.46 Million | $49.59 Million | ▼ -0.3 pp |
| 2019 | 48.9% | $51.09 Million | $104.55 Million | $53.46 Million | ▼ -0.4 pp |
| 2018 | 49.3% | $55.57 Million | $112.69 Million | $57.12 Million | ▼ -19.3 pp |
| 2017 | 68.6% | $63.92 Million | $93.23 Million | $29.31 Million | ▼ -9.7 pp |
| 2016 | 78.3% | $73.12 Million | $93.40 Million | $20.28 Million | ▼ -5.3 pp |
| 2015 | 83.6% | $76.82 Million | $91.92 Million | $15.10 Million | ▼ -1.1 pp |
| 2014 | 84.6% | $80.75 Million | $95.41 Million | $14.65 Million | ▼ -5.9 pp |
| 2013 | 90.5% | $79.29 Million | $87.61 Million | $8.32 Million | ▲ +3.7 pp |
| 2012 | 86.8% | $85.57 Million | $98.59 Million | $13.03 Million | ▲ +0.1 pp |
| 2011 | 86.7% | $82.84 Million | $95.52 Million | $12.68 Million | ▲ +2.3 pp |
| 2010 | 84.4% | $77.72 Million | $92.05 Million | $14.34 Million | ▲ +14.8 pp |
| 2009 | 69.6% | $72.22 Million | $103.72 Million | $31.50 Million | ▲ +13.2 pp |
| 2008 | 56.4% | $17.55 Million | $31.12 Million | $13.56 Million | ▼ -1.5 pp |
| 2007 | 57.9% | $16.75 Million | $28.92 Million | $12.17 Million | ▲ +15.9 pp |
| 2006 | 42.0% | $11.13 Million | $26.48 Million | $15.36 Million | ▼ -19.3 pp |
| 2005 | 61.3% | $6.23 Million | $10.17 Million | $3.94 Million | — |